Eye disease entrepreneurs raise $16M for Azura Ophthalmics

Frank
May 9, 2018
18 Views

Azura Ophthalmics, which is developing therapies to combat meibomian gland dysfunction (MGD), an underlying cause of dry eye disease, closed a $16 million Series B funding round. The fresh capital will be used to advance the treatment, which uses a dermatological approach to the condition, through clinical trials.

A syndicate of investors including OrbiMed, TPG Biotech and Brandon Capital’s Medical Research Commercialisation Fund led the Series B for the Tel Aviv-based business. Ganot Capital also took part.

The founders of Azura have cut their teeth in the eye treatment sector. Dr. Yair Alster, founder and CTO, helped start ForSight Vision4. The company was created with ophthalmic incubator ForSight Labs and acquired by Roche-Genentech earlier this year. He also cofounded ForSight Vision 5, which Allergan acquired last year. CEO Marc Gleeson worked for 14 years as Allergan vice president of global marketing for Ophthalmology before joining Oculeve.

The dry eye disease space has been fairly active in the past few years. Oculeve, which developed a nasal neurostimulation tool to increase tear production, came out of Stanford University’s Biodesign program and received investment from Kleiner Perkins Caulfield and Byers, New Enterprise Associates and Versant Ventures. Allergan acquired the business in 2015. The FDA granted market authorization for the TrueTear Intranasal Tear Neurostimulator in April this year.

In August Johnson & Johnson’s vision business said it agreed to acquire TearScience in Research Triangle Park. TearScience had received FDA clearance for its LipiFlow treatment for dry eye disease in 2012

Other players in the space see a need for dry eye disease tied to other causes. Ocunova, for example, developed a therapeutic for diabetes-related dry eye syndrome, which can cause corneal damage. The treatment enlists a drug already approved by the FDA to manage alcohol and drug dependence called Naltrexone. The company noted on its website that chronic dry eye disease in diabetes patients affects 20 million people in the U.S.

Photo: Jay_Zynism, Getty Images

Frank’s source: https://medcitynews.com/2017/10/eye-disease-entrepreneurs/

 

You may be interested

Overcoming the stumbling blocks of digital health adoption
About Health
0 shares1 views
About Health
0 shares1 views

Overcoming the stumbling blocks of digital health adoption

Frank - May 23, 2018

Achieving perfection in the realm of digital health adoption is far from an easy feat. Numerous barriers prevent perfect deployment,…

Jean-Claude Van Damme’s youngest son arrested after ‘holding his flatmate at knifepoint’
About Entertainment
0 shares2 views
About Entertainment
0 shares2 views

Jean-Claude Van Damme’s youngest son arrested after ‘holding his flatmate at knifepoint’

Frank - May 23, 2018

Hollywood star Jean-Claude Van Damme's youngest son has been arrested for allegedly taking his flatmate prisoner with a knife. Police were…

Star Wars 9: Release date for Episode IX has been delayed
About Entertainment
0 shares2 views
About Entertainment
0 shares2 views

Star Wars 9: Release date for Episode IX has been delayed

Frank - May 23, 2018

After Star Wars: Episode IX's dramatic change in personnel, which saw J.J. Abrams step in as director after Colin Trevorrow's…

Leave a Comment

Your email address will not be published.

two + nineteen =